Bone Biologics Corp (NASDAQ:BBLG) has seen 0.77 million shares traded in the recent trading session. The company, currently valued at $0.90M, closed the recent trade at $1.70 per share which meant it gained $0.22 on the day or 14.86% during that session. The BBLG stock price is -521.18% off its 52-week high price of $10.56 and 52.94% above the 52-week low of $0.80. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.32 million shares traded. The 3-month trading volume is 4.90 million shares.
Bone Biologics Corp (NASDAQ:BBLG) trade information
Sporting 14.86% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the BBLG stock price touched $1.70 or saw a rise of 16.67%. Year-to-date, Bone Biologics Corp shares have moved -62.39%, while the 5-day performance has seen it change -1.16%. Over the past 30 days, the shares of Bone Biologics Corp (NASDAQ:BBLG) have changed -1.73%. Short interest in the company has seen 0.35 million shares shorted with days to cover at 0.04.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bone Biologics Corp (BBLG) estimates and forecasts
Figures show that Bone Biologics Corp shares have outperformed across the wider relevant industry. The company’s shares have lost -3.95% over the past 6 months, with this year growth rate of 90.68%, compared to 17.40% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 42.24% over the past 5 years.
BBLG Dividends
Bone Biologics Corp is expected to release its next earnings report on 2024-Nov-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Bone Biologics Corp (NASDAQ:BBLG)’s Major holders
Insiders own 5.21% of the company shares, while shares held by institutions stand at 3.23% with a share float percentage of 3.41%. Investors are also buoyed by the number of investors in a company, with Bone Biologics Corp having a total of 7.0 institutions that hold shares in the company. The top two institutional holders are UBS GROUP AG with over 33707.0 shares worth more than $41123.0. As of 2024-06-30, UBS GROUP AG held 5.1% of shares outstanding.
The other major institutional holder is HRT FINANCIAL LP, with the holding of over 17519.0 shares as of 2024-06-30. The firm’s total holdings are worth over $21000.0 and represent 2.6507% of shares outstanding.
